You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 6, June 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Cerebrovascular Disease
 •Neurology, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cerebral Microbleeds

Evidence of Heightened Risk Associated With Aspirin Use

Philip B. Gorelick, MD, MPH

Arch Neurol. 2009;66(6):691-693.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In recent years, interest in cerebral microbleeds (CMs) has increased based on advances in magnetic resonance imaging (MRI) technology. Both MRI T2-weighted gradient-echo (GRE) and susceptibility-weighted imaging may be sensitive techniques for the detection of past and more recent brain hemorrhage.1-2 For example, GRE sequences may identify microbleeds because hemosiderin remains in macrophages for years after hemorrhage, and such deposits rim hemorrhage cavities. In addition, CMs may be defined as rounded foci 5-10 mm or smaller that appear hypointense (dark holes) on appropriate MRI sequences. They may appear larger on GRE sequences compared with actual tissue lesion size because a blooming effect of the MRI signal may occur at the lesion border.1 The Microbleed Study Group provides an up-to-date guide to the detection and interpretation of CMs and suggests possible future approaches for elucidating the role of these lesions.3

The underlying vessel disease of cerebral . . . [Full Text of this Article]

STUDY DESIGN


MAIN STUDY RESULTS

INTERPRETATION OF STUDY RESULTS

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Use of Antithrombotic Drugs and the Presence of Cerebral Microbleeds: The Rotterdam Scan Study
Meike W. Vernooij, Mendel D. M. Haag, Aad van der Lugt, Albert Hofman, Gabriel P. Krestin, Bruno H. Stricker, and Monique M. B. Breteler
Arch Neurol. 2009;66(6):714-720.
ABSTRACT | FULL TEXT  

This Month in Archives of Neurology
Arch Neurol. 2009;66(6):689-690.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.